In treating flare-ups in chronic obstructive pulmonary disease (COPD), a major cause of disability and the fourth leading cause of death in the U.S, what was old is important again. University at Buffalo researchers Sanjay Sethi, M.D., and Timothy F. Murphy, M.D., principal investigators on the longest-running study of infection in COPD patients in
Full Post: Study looks at ‘vicious circle’ theory infections in COPD patients
Computer programs designed to help radiologists could identify more cases of breast cancer, but they might also increase the number of false-positive results, which can lead to biopsies in healthy women, according to a recent systematic review.
Using computer-aided detection (CAD) mammography, “you do catch some cases that would have been missed if the mammogram had been read only by a single radiologist,” said review author Meredith Noble, a research analyst at ECRI Institute.
Typically, a radiologist examines a woman’s screening mammogram to check for signs of cancer. When using CAD with mammography, the radiologist still reads the mammogram, but a computer program also evaluates the mammogram and marks suspicious areas for the radiologist to review further.
Investigators led by Noble synthesized data from seven previously published studies of CAD mammography’s use in 392,015 healthy women with no lumps or other symptoms of breast cancer.
The current report, released this month, is an update of an earlier review also published by ECRI Institute, a nonprofit health services research agency that produces systematic evidence reviews on medical devices, drugs, biotechnologies and procedures.
Investigators found that in women with no symptoms, screening with CAD mammography identified an estimated 84.2 percent to 87.6 percent of women with cancer, a finding referred to as test sensitivity.
In addition, an estimated 88.1 percent to 88.3 percent of healthy women correctly received negative test results when undergoing CAD mammography, a finding referred to as test specificity.
Researchers compared CAD mammography results to biopsy results and patient follow-up records to determine whether if the women received a breast cancer diagnosis within a year after the mammogram.
The updated evidence review indicated that CAD mammography helped identify an estimated 50 additional cancer diagnoses for every 100,000 women who underwent the screening test, compared to having the mammogram read only by a radiologist.
The analysis also estimated that following CAD mammography, between 1,090 and 1,290 women per 100,000 healthy women - women who did not have breast cancer - would be recalled for further testing in the form of more imaging studies or biopsy based on abnormal mammogram results.
ECRI Institute estimated that 80 of those women who had false-positive results would undergo biopsy.
Joshua Fenton, M.D, a researcher who focuses on breast cancer screening, said a concern “is that we may have variability in how doctors are using this technology.” He said that some providers might simply rely on CAD to catch potentially cancerous areas, instead of interpreting the mammogram first and using CAD as secondary analysis tool.
“That might result in a different outcome in the community,” Fenton said.
Fenton, an assistant professor at the University of California-Davis, has no affiliation with the ECRI review.
Based on the evidence review, Fenton agreed with the authors that there are not enough data to say for sure that CAD has clear public health benefits, that it improves breast cancer mortality or that it helps doctors detect the most dangerous breast cancer.
Although the results of this evidence report pertain mainly to health care providers, patients do need to know about the advantages and potential drawbacks of CAD mammography, Noble said. Most notably, physicians should tell women who undergo CAD mammography screenings that there are more false positives when CAD is used.
False-positive findings can provoke anxiety, but some women and their doctors might find them to be an acceptable trade-off for identifying some additional cancers, Noble added.
CAD mammography received approval by the U.S. Food and Drug Administration in 1998.
ECRI Institute, is a nonprofit international health services research agency that provides information and technical assistance to the health care community. ECRI Institute is designated a Collaborating Center of the World Health Organization and an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality.
Noble M, et al. Computer-aided detection (CAD) mammography for breast cancer screening. ECRI Health Technology Information Service, 2008.
http://www.hbns.org
--------------------------------------------------------------------------------------------
Related Posts:
Magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast cancers not identified by mammography alone, a research team from The University of Texas M. D. Anderson Cancer Center will report at the 31st at the CRTC-AACR San Antonio Breast Cancer Symposium. MRI is known to be more sensitive in detecting breast
Full Post: Magnetic resonance imaging alternated with mammography may be best for high-risk women
Breast-Specific Gamma Imaging (BSGI) is shown to be an effective method of identifying mammographically and clinically occult (hidden) breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. According to findings presented today at the annual meeting of the Radiological Society of
Full Post: Breast-specific gamma imaging identifies hidden breast cancer
According to researchers in Norway mammograms may detect some cancers that would have otherwise regressed. There has been a significant increase in breast cancer rates in some parts of Norway since women there began undergoing mammography every two years and the rates among regularly screened women have remained higher than rates among women of the
Full Post: Mammograms may pick up breast cancers which would have disappeared
A retail and healthcare combo service is now available to women in New South Wales with the opening of breast cancer clinics in three department stores in Sydney’s western suburbs. The Breast Cancer Institute (BCI) initiative kicks off this week with the opening of the first breast cancer clinic in Myers in Parramatta. The New
Full Post: Mammograms on offer at Myers!
A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman’s hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. Results will be presented at the annual meeting of the Radiological Society of
Full Post: Positron emission mammography effective in detecting breast cancer --------------------------------------------------------------------------------------------
